Michael Simoff

TL;DR: BT in subjects with severe asthma improves asthma-specific quality of life with a reduction in severe exacerbations and healthcare use in the posttreatment period, and is superior in the BT group compared with sham.

TL;DR: Peripheral TBNA improved diagnostic yield for peripheral lesions but was underused, and the diagnostic yields of EMN and r-EBUS were lower than expected, even after adjustment.

TL;DR: Current smoking at diagnosis is an important independent predictor of shortened lung cancer survival and that this effect was not explained by sociodemographic/exposure factors, adverse symptoms, histology, stage, comorbidity, and treatment suggests that it may be mediated through direct biological effects.

TL;DR: Comorbidity has a major impact on survival in early‐ and late‐stage disease, and even infrequent deleterious comorbidities are important collectively.

TL;DR: In this paper, the authors evaluated the effectiveness and safety of bronchial thermoplasty (BT) in patients with severe persistent asthma 5 years after therapy and showed that BT has become an important addition to our treatment armamentarium and should be considered for patients with mild to moderate asthma who remain symptomatic despite taking inhaled corticosteroids and long-acting β 2 -agonists.